These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 8158129

  • 1. Sequestration of muscarinic cholinergic receptors in permeabilized neuroblastoma cells.
    Slowiejko DM, Levey AI, Fisher SK.
    J Neurochem; 1994 May; 62(5):1795-803. PubMed ID: 8158129
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The aminosteroid U-73122 inhibits muscarinic receptor sequestration and phosphoinositide hydrolysis in SK-N-SH neuroblastoma cells. A role for Gp in receptor compartmentation.
    Thompson AK, Mostafapour SP, Denlinger LC, Bleasdale JE, Fisher SK.
    J Biol Chem; 1991 Dec 15; 266(35):23856-62. PubMed ID: 1660886
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cells: desensitization by receptor agonists.
    Xu J, Chuang DM.
    J Pharmacol Exp Ther; 1987 Jul 15; 242(1):238-44. PubMed ID: 3039110
    [Abstract] [Full Text] [Related]

  • 6. Reduction of muscarinic receptor density and of guanine nucleotide-stimulated phosphoinositide hydrolysis in human SH-SY5Y neuroblastoma cells following long-term treatment with 12-O-tetradecanoylphorbol 13-acetate or mezerein.
    Cioffi CL, Fisher SK.
    J Neurochem; 1990 May 15; 54(5):1725-34. PubMed ID: 2157816
    [Abstract] [Full Text] [Related]

  • 7. Mechanism of agonist-induced down-regulation and subsequent recovery of muscarinic acetylcholine receptors in a clonal neuroblastoma x glioma hybrid cell line.
    Ray P, Middleton W, Berman JD.
    J Neurochem; 1989 Feb 15; 52(2):402-9. PubMed ID: 2562988
    [Abstract] [Full Text] [Related]

  • 8. Muscarinic receptor regulation of cytoplasmic Ca2+ concentrations in human SK-N-SH neuroblastoma cells: Ca2+ requirements for phospholipase C activation.
    Fisher SK, Domask LM, Roland RM.
    Mol Pharmacol; 1989 Feb 15; 35(2):195-204. PubMed ID: 2537457
    [Abstract] [Full Text] [Related]

  • 9. Agonist-induced alteration in the membrane form of muscarinic cholinergic receptors.
    Harden TK, Petch LA, Traynelis SF, Waldo GL.
    J Biol Chem; 1985 Oct 25; 260(24):13060-6. PubMed ID: 4055732
    [Abstract] [Full Text] [Related]

  • 10. Regulation of muscarinic agonist-induced activation of phosphoinositidase C in electrically permeabilized SH-SY5Y human neuroblastoma cells by guanine nucleotides.
    Wojcikiewicz RJ, Lambert DG, Nahorski SR.
    J Neurochem; 1990 Feb 25; 54(2):676-85. PubMed ID: 2153757
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
    Baker SP, Posner P.
    Mol Pharmacol; 1986 Nov 25; 30(5):411-8. PubMed ID: 3773882
    [Abstract] [Full Text] [Related]

  • 13. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M, Waelbroeck M, Christophe J.
    Mol Pharmacol; 1987 Jul 25; 32(1):100-8. PubMed ID: 3600611
    [Abstract] [Full Text] [Related]

  • 14. A comparison between muscarinic receptor occupancy, inositol 1,4,5-trisphosphate accumulation and Ca2+ mobilization in permeabilized SH-SY5Y neuroblastoma cells.
    Safrany ST, Nahorski SR.
    Neuropharmacology; 1994 Jul 25; 33(7):837-46. PubMed ID: 7969802
    [Abstract] [Full Text] [Related]

  • 15. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
    Tucek S, Musílková J, Nedoma J, Proska J, Shelkovnikov S, Vorlícek J.
    Mol Pharmacol; 1990 Nov 25; 38(5):674-80. PubMed ID: 2233700
    [Abstract] [Full Text] [Related]

  • 16. Evidence of paired M2 muscarinic receptors.
    Potter LT, Ballesteros LA, Bichajian LH, Ferrendelli CA, Fisher A, Hanchett HE, Zhang R.
    Mol Pharmacol; 1991 Feb 25; 39(2):211-21. PubMed ID: 1899905
    [Abstract] [Full Text] [Related]

  • 17. Relationship between agonist-induced muscarinic receptor loss and desensitization of stimulated phosphoinositide turnover in two neuroblastomas: methodological considerations.
    Thompson AK, Fisher SK.
    J Pharmacol Exp Ther; 1990 Feb 25; 252(2):744-52. PubMed ID: 2156059
    [Abstract] [Full Text] [Related]

  • 18. Analysis of cardiac muscarinic receptors recognized selectively by nonquaternary but not by quaternary ligands.
    Brown JH, Goldstein D.
    J Pharmacol Exp Ther; 1986 Aug 25; 238(2):580-6. PubMed ID: 3016242
    [Abstract] [Full Text] [Related]

  • 19. Presence of m3 subtype muscarinic acetylcholine receptors and receptor-mediated increases in the cytoplasmic concentration of Ca2+ in Jurkat, a human leukemic helper T lymphocyte line.
    Kaneda T, Kitamura Y, Nomura Y.
    Mol Pharmacol; 1993 Mar 25; 43(3):356-64. PubMed ID: 8383801
    [Abstract] [Full Text] [Related]

  • 20. Prevention of guanine nucleotide-induced reductions in muscarinic agonist binding to rabbit ileal submucosal membranes by lidamidine and tetracaine.
    Bleakman D, Naftalin RJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr 25; 337(4):366-72. PubMed ID: 2900471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.